Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT). (2022)
Attributed to:
Metabolism and drug resistance probed with new genetic tools in the neglected animal pathogen Trypanosoma vivax.
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.2c00791
PubMed Identifier: 35993839
Publication URI: http://europepmc.org/abstract/MED/35993839
Type: Journal Article/Review
Volume: 65
Parent Publication: Journal of medicinal chemistry
Issue: 17
ISSN: 0022-2623